Alec Morton
Associate Professor
Biography
Dr Alec Morton is an Associate Professor (Practice) in the Saw Swee Hock School of Public Health at the National University of Singapore (NUS), where he also serves as Director of the Centre for Population Health Risk Informatics and Simulation Modelling (PHRISM). He holds a joint appointment at Duke-NUS Medical School and an associate appointment at the Singapore University of Social Sciences. He is also Professor of Management Science at the University of Strathclyde in the UK, and has held academic positions at the London School of Economics. Dr Morton's work lies at the intersection of decision science and health economics, with a particular focus on improving priority setting in health systems. His research spans health technology assessment (HTA), multi-criteria decision analysis (MCDA), structured expert elicitation, cost-effectiveness analysis, and simulation modelling. These tools are applied to a wide range of policy domains, including precision medicine, antimicrobial resistance, mental health, and public health preparedness. He has worked closely with national health authorities and international agencies such as the World Health Organization, the Global Fund, and the Center for Global Development. His research engages with applied and policy-relevant questions in collaboration with national and international partners. He has worked with Thailand's Health Intervention and Technology Assessment Program (HITAP) on frameworks to evaluate HTA agencies, and with the Center for Global Development on models for aid allocation and strategic planning for global health investments. He was also a co-author of the World Health Organization's report What Counts in Economic Evaluation, which has contributed to the organisation's evolving approach to investment cases and funding prioritisation. He previously led a responsive modelling facility for the UK Department of Health, focusing on modelling to support health protection in areas such as antimicrobial resistance and infectious disease control, and conducted research on the government's subscription-style funding model for novel antimicrobials. These projects reflect his broader interest in how decision science can inform health system design and support accountable and transparent resource allocation. A committed educator and mentor, Dr Morton is the founding director of the MSc in Health Economics and Outcomes Research (MScHEOR) at NUS. He is dedicated to developing health economics capacity across the Asia-Pacific region and regularly collaborates with partners in both high-income and low- and middle-income countries. He is a member of the International Health Economics Association and the International Society for Pharmacoeconomics and Outcomes Research.
Sample for utility
In terms of number of respondents required for utility data, is there any standardized formula to calculate? And whether it is justifiable to calculate using proportion estimation? In case of the limited sample (e.g. rare disease, low survival rate) and do not meet the expected sample (as calculat...
Expected Value of Perfect Information
How useful really is Expected Value of Perfect Information as an additional analysis to support decision-making for the healthcare system? Are there settings/countries now who are conducting this as part of their standard analysis to complement the results of cost effectiveness analysis?
CEA on Road Safety Policies
"Dear professor, Currently, we have so many road safety policies to reduce the number of casualties and deaths. The WHO guideline recommends the use of CEA for policies, measuring the outcomes in terms of death reductions or casualty reductions. The thing is we don't know which specific policy is ac...
Plotting ICER result on cost-effectiveness plane and putting PSA in CEAC
Dear Expert, I have values for both the incremental cost and incremental DALY/QALY. How do I put them on cost-effectiveness plane or how do I plot them in graph, so that I get nice graph showing ICER result on cost-effectiveness plane? number 2: I have all the values from PSA. How do I put them in ...
Choice of journal for publication
Which journal should I go for a publication of research on Economic evaluation of vaccine?
How to transfer distribution of probability parameter from 5 years into 1 year
Dear Dr and Prof, I'm trying to find probability parameters for my model of chronic hepatitis B. However, most study I found come from observational studies, with different duration of follow-up . In my model, I need the probability and the parameters for beta distribution (alpha, beta). And I don'...